These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8002146)

  • 21. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
    Ablon G; Rosen T; Spedale J
    Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
    Chadeganipour M; Nilipour S; Havaei A
    Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes.
    Ghannoum MA; Welshenbaugh A; Imamura Y; Isham N; Mallefet P; Yamaguchi H
    Mycoses; 2010 Jul; 53(4):311-3. PubMed ID: 19422522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of TDT 067 (terbinafine in Transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations.
    Ghannoum M; Isham N; Herbert J; Henry W; Yurdakul S
    J Clin Microbiol; 2011 May; 49(5):1716-20. PubMed ID: 21411586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?
    Shen JJ; Arendrup MC; Verma S; Saunte DML
    Dermatology; 2022; 238(1):60-79. PubMed ID: 34058736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of the allylamines.
    Birnbaum JE
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):782-5. PubMed ID: 2229523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.
    Jessup CJ; Warner J; Isham N; Hasan I; Ghannoum MA
    J Clin Microbiol; 2000 Jan; 38(1):341-4. PubMed ID: 10618112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
    Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of susceptibility of dermatophytes to antifungal drugs].
    Macura AB; Filip E; Pawlik B
    Med Dosw Mikrobiol; 1993; 45(2):253-7. PubMed ID: 8309309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of some synthesized thiazoles against dermatophytes.
    Ouf SA; Taleb AM; Tharwat NA; Geweely NS
    J Mycol Med; 2013 Dec; 23(4):230-6. PubMed ID: 24129248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of the in vitro activity of terbinafine.
    Jessup CJ; Ryder NS; Ghannoum MA
    Med Mycol; 2000 Apr; 38(2):155-9. PubMed ID: 10817232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.
    Araújo CR; Miranda KC; Fernandes Ode F; Soares AJ; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2009; 51(1):9-12. PubMed ID: 19229384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.
    Stütz A; Georgopoulos A; Granitzer W; Petranyi G; Berney D
    J Med Chem; 1986 Jan; 29(1):112-25. PubMed ID: 3510297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
    Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
    Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].
    Goudard M; Buffard Y; Ferrari H; Regli P
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):680-3. PubMed ID: 3534767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
    Badali H; Mohammadi R; Mashedi O; de Hoog GS; Meis JF
    Mycoses; 2015 May; 58(5):303-7. PubMed ID: 25757042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.